Evidence map›Paper›PMID 29074847›Full record

ArticleScientific reports2017

Recommendation for incorporation of a different lymph node scoring system in future AJCC N category for oral cancer.

Ching-Chih Lee, Yu-Chieh Su, Shih-Kai Hung, Po-Chun Chen, Chung-I Huang, Wei-Lun Huang, Yu-Wei Lin, Ching-Chieh Yang

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. The log odds of positive neck lymph nodes is a superior lymph node predictor for overall survival in head and neck cancer: a population-based analysis in Germany.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tumor SuppressorFrontiers in oncology · 2020
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ching-Chih LeeDepartment of Otolaryngology, Head and Neck Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Yu-Chieh SuDepartment of Hematology and Oncology, E-Da hospital, Kaohsiung, Taiwan.
Shih-Kai HungDepartment of Radiation Oncology, Buddhist Dalin Tzu Chi Hospital, Chiayi, Taiwan.
Po-Chun ChenDepartment of Radiation Oncology, Pingtung Christian Hospital, Pingtung, Taiwan.
Chung-I HuangDepartment of Radiation Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan.
Wei-Lun HuangDepartment of Radiation oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Yu-Wei LinDepartment of Radiation Oncology, Chi-Mei Medical Center, Tainan, Taiwan.
Ching-Chieh YangDepartment of Radiation Oncology, Chi-Mei Medical Center, Tainan, Taiwan. cleanclear0905@gmail.com.ORCID 0000-0003-3823-4673

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To compare the prognostic value of 3 different lymph node scoring systems " log odds of positive nodes (LODDS), lymph node ratio (rN), and lymph node yield " in an effort to improve the staging of oral cancer. We identified 3958 oral cancer patients from Surveillance, Epidemiology, and End Results database from 2007 to 2013. In univariate analysis, LODDS, pN, rN, and lymph node yield were prognostic factors for 5-year disease-specific survival (DSS) and overall survival (OS). Multivariate analysis indicated that patients with LODDS 4 had worst 5-year DSS and OS. Stage migration occurred in pN1 and pN2 patients with LODDS 4. In pN1 patients, those with LODDS 4 had the worst 5-year DSS (41.2%) and OS (31.6%) than patients with pN1 and LODDS 2-3. In pN2 patients, those with LODDS4 had the worst 5-year DSS (34.5%) and OS (27.4%) than patients with pN2 and LODDS 2-3. The proposed staging system, which incorporates LODDS with AJCC pN, had better discriminability and prediction accuracy for predicting survival. We also noted that patients with LODDS 4 given adjuvant radiotherapy had better 5-year DSS and OS. The LODDS should be considered as a future candidate measurement for N category in oral cancer.

Indexed as

FemaleHumansLymphatic MetastasisLymph NodesMaleMiddle AgedMouth NeoplasmsMultivariate AnalysisNeoplasm StagingRadiotherapy, AdjuvantRisk

Identifiers

PMID29074847
PMCPMC5658398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.